Debjani Sahni | Profiles RNS

Debjani Sahni, MBBS

Dr. G. Robert Baler Junior Faculty Professor

Boston University School of Medicine

Dept of Dermatology

MBBS, King's College London

Websites

	Dermatology Faculty
	Boston Medical Center Physician Provider Profile

ORCID : 0000-0001-7203-3109

Dr. Sahni joined the BUSM faculty as an instructor of Dermatology and staff dermatologist at Boston Medical Center in 2011. She was promoted to assistant professor in 2012 and serves as director of the multi-disciplinary Cutaneous Oncology Program. She specializes in the care of cutaneous oncology patients, including cutaneous lymphomas and the medical management of melanoma and high-risk non-melanoma skin cancers. Dr. Sahni also directs the Cutaneous Oncology Fellowship and the International Program in Dermatology (IGPD). First established in 1988, the IGPD offers international postgraduate doctors the opportunity to train in dermatology, utilizing state-of-the-art facilities and therapies available in the US. Dr. Sahni’s clinical research interests focus on the epidemiology and treatment of skin cancers. She is a member of the Medical Advisory Council for the Cutaneous Lymphoma Foundation. Her academic interests include teaching and mentoring. She has lectured both in Europe and the US, and is the author of a number of scientific papers. Since her arrival seven years ago, she has received four Department of Dermatology Teacher of the Year awards. Dr. Sahni received her MBBS from the United Medical and Dental Schools of Guy’s and St Thomas’ Hospitals in London. After finishing her internal medicine residency she acquired her MRCP (Membership of the Royal College of Physicians) and completed a dermatology residency at the St John’s Institute of Dermatology in London followed by a cutaneous oncology fellowship at Dana-Farber Cancer Institute/Brigham and Women’s Hospital, Boston.

Director
Boston University School of Medicine
Dermatology
Cutaneous Oncology

BMC Sponsored Research

EL-1007-01-01
03/16/2018 - 03/16/2021 (PI)
Elorac Inc

Cutaneous Oncology Fellowship
08/03/2012 - 06/30/2017 (PI)
Mallinckrodt LLC

Cutaneous Oncology Fellowship
07/03/2012 - 06/30/2016 (PI)
Genentech

Yr	Title	Project-Sub Proj	Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

Ho JD, Chung HJ, Ms Barron A, Ho DA, Sahni D, Browning JL, Bhawan J. Extensive CD34-to-CD90 Fibroblast Transition Defines Regions of Cutaneous Reparative, Hypertrophic, and Keloidal Scarring. Am J Dermatopathol. 2019 Jan; 41(1):16-28.View Related Profiles.
Sahni, Debjani
Chung, Hye Jin
Bhawan, Jag
Browning, Jeffrey
PMID: 30320623.
Abbott JL, Qureshi MM, Truong MT, Sahni D. Comparing survival outcomes in early stage desmoplastic melanoma with or without adjuvant radiation. Melanoma Res. 2018 Oct 31.View Related Profiles.
Sahni, Debjani
Truong, Minh
Qureshi, Muhammad
PMID: 30383720.
Jeter JM, Bowles TL, Curiel-Lewandrowski C, Swetter SM, Filipp FV, Abdel-Malek ZA, Geskin LJ, Brewer JD, Arbiser JL, Gershenwald JE, Chu EY, Kirkwood JM, Box NF, Funchain P, Fisher DE, Kendra KL, Marghoob AA, Chen SC, Ming ME, Albertini MR, Vetto JT, Margolin KA, Pagoto SL, Hay JL, Grossman D, Ellis DL, Kashani-Sabet M, Mangold AR, Markovic SN, Nelson KC, Powers JG, Robinson JK, Sahni D, Sekulic A, Sondak VK, Wei ML, Zager JS, Dellavalle RP, Thompson JA, Weinstock MA, Leachman SA, Cassidy PB. Chemoprevention agents for melanoma: A path forward into phase 3 clinical trials. Cancer. 2019 Jan 01; 125(1):18-44. PMID: 30281145.
Ho JD, Al-Haseni A, Smith S, Bhawan J, Sahni D. Bullous complex regional pain syndrome: A description of the clinical and histopathologic features. J Cutan Pathol. 2018 Aug; 45(8):633-635.View Related Profiles.
Sahni, Debjani
Bhawan, Jag
PMID: 29704267.
Singh B, Qureshi MM, Truong MT, Sahni D. Optimal Surgical Modality for Early Merkel Cell Carcinoma-Results from the National Cancer Data Base. J Am Acad Dermatol. 2018 May 19.View Related Profiles.
Sahni, Debjani
Truong, Minh
Qureshi, Muhammad
PMID: 29787838.
Gionfriddo MR, Pulk RA, Sahni DR, Vijayanagar SG, Chronowski JJ, Jones LK, Evans MA, Feldman SR, Pride H. ProvenCare-Psoriasis: A disease management model to optimize care. Dermatol Online J. 2018 Mar 15; 24(3). PMID: 29634876.
Singh B, Qureshi MM, Truong MT, Sahni D. Demographics and outcomes of stage I and II Merkel cell carcinoma treated with Mohs micrographic surgery compared with wide local excision in the National Cancer Database. J Am Acad Dermatol. 2018 Jul; 79(1):126-134.e3.View Related Profiles.
Sahni, Debjani
Truong, Minh
Qureshi, Muhammad
PMID: 29408552.
Min MS, Al-Haseni A, Succaria F, Goldberg L, Lerner A, Sahni D. Anaplastic large cell lymphoma localized to the left breast years after radiotherapy for breast cancer. Dermatol Online J. 2018 Jan 15; 24(1).View Related Profiles.
Lerner, Adam
Sahni, Debjani
Goldberg, Lynne
PMID: 29469762.
Al-Haseni A, Chitgopeker P, Ho JD, Goldberg LJ, Sahni D. Amelanotic melanoma arising within a lesion of disseminated superficial actinic porokeratosis: An unusual presentation leading to a novel therapeutic approach. Dermatol Ther. 2018 Jan; 31(1).View Related Profiles.
Sahni, Debjani
Goldberg, Lynne
PMID: 28976625.
Patel SA, Qureshi MM, Sahni D, Truong MT. Identifying an Optimal Adjuvant Radiotherapy Dose for Extremity and Trunk Merkel Cell Carcinoma Following Resection: An Analysis of the National Cancer Database. JAMA Dermatol. 2017 Oct 01; 153(10):1007-1014.View Related Profiles.
Sahni, Debjani
Truong, Minh
Qureshi, Muhammad
PMID: 28746702.

Showing 10 of 22 results. Show More

Ho JD, Kam SA, Al-Haseni A, Markova A, Sahni D, Lam C, Goldberg LJ, Bhawan J. Benign and malignant hybrid adnexal tumors in a patient with epidermodysplasia verruciformis. J Cutan Pathol. 2017 Nov; 44(11):969-973.View Related Profiles.
Lam, Christina
Sahni, Debjani
Bhawan, Jag
Goldberg, Lynne
PMID: 28796338.
Patel SA, Qureshi MM, Mak KS, Sahni D, Giacalone NJ, Ezzat W, Jalisi S, Truong MT. Impact of total radiotherapy dose on survival for head and neck Merkel cell carcinoma after resection. Head Neck. 2017 Jul; 39(7):1371-1377.View Related Profiles.
Sahni, Debjani
Mak, Kimberley
Truong, Minh
Qureshi, Muhammad
Jalisi, Scharukh
Ezzat, Waleed
PMID: 28370725; DOI: 10.1002/hed.24776;.
Johnson MM, Leachman SA, Aspinwall LG, Cranmer LD, Curiel-Lewandrowski C, Sondak VK, Stemwedel CE, Swetter SM, Vetto J, Bowles T, Dellavalle RP, Geskin LJ, Grossman D, Grossmann KF, Hawkes JE, Jeter JM, Kim CC, Kirkwood JM, Mangold AR, Meyskens F, Ming ME, Nelson KC, Piepkorn M, Pollack BP, Robinson JK, Sober AJ, Trotter S, Venna SS, Agarwala S, Alani R, Averbook B, Bar A, Becevic M, Box N, E Carson W, Cassidy PB, Chen SC, Chu EY, Ellis DL, Ferris LK, Fisher DE, Kendra K, Lawson DH, Leming PD, Margolin KA, Markovic S, Martini MC, Miller D, Sahni D, Sharfman WH, Stein J, Stratigos AJ, Tarhini A, Taylor MH, Wisco OJ, Wong MK. Skin cancer screening: recommendations for data-driven screening guidelines and a review of the US Preventive Services Task Force controversy. Melanoma Manag. 2017 Mar; 4(1):13-37.View Related Profiles.
Sahni, Debjani
Alani, Rhoda
PMID: 28758010.
Suaiti L, Al-Haseni A, Lee H, Sahni D. Iris mammillations in a pair of twins with Cowden syndrome. JAAD Case Rep. 2016 Jul; 2(4):323-5.View Related Profiles.
Sahni, Debjani
Lee, Hyunjoo
PMID: 27570815; PMCID: PMC4992003; DOI: 10.1016/j.jdcr.2016.07.004;.
Succaria F, Sahni D, Wolpowitz D. Rituximab-Induced Serum Sickness-Like Reaction: A Histopathologic Viewpoint. Am J Dermatopathol. 2016 Apr; 38(4):321-2. PMID: 26999343; DOI: 10.1097/DAD.0000000000000356;.
Robson A, Shukur Z, Ally M, Kluk J, Liu K, Pincus L, Sahni D, Sundram U, Subtil A, Karai L, Kempf W, Schieke S, Coates P. Immunocytochemical p63 expression discriminates between primary cutaneous follicle centre cell and diffuse large B cell lymphoma-leg type, and is of the TAp63 isoform. Histopathology. 2016 Jul; 69(1):11-9. PMID: 26332336; DOI: 10.1111/his.12855;.
Chitgopeker P, Sahni D. T-cell receptor gene rearrangement detection in suspected cases of cutaneous T-cell lymphoma. J Invest Dermatol. 2014 Apr; 134(4):e19. PMID: 24646806; DOI: 10.1038/jid.2014.73;.
Jennings L, Campbell SM, Yaar R, Mahalingam M, Sahni D, Lerner A, Rünger TM. Generalized syringotropic mycosis fungoides responsive to extracorporeal photopheresis. Br J Dermatol. 2014 Jan; 170(1):200-2.View Related Profiles.
Lerner, Adam
Sahni, Debjani
Mahalingam, Meera
PMID: 23909445; DOI: 10.1111/bjd.12547;.
Okafor PN, Stallwood CG, Nguyen L, Sahni D, Wasan SK, Farraye FA, Erim DO. Cost-effectiveness of nonmelanoma skin cancer screening in Crohn's disease patients. Inflamm Bowel Dis. 2013 Dec; 19(13):2787-95.View Related Profiles.
Sahni, Debjani
Farraye, Francis
Wasan, Sharmeel
PMID: 24193153; DOI: 10.1097/01.MIB.0000435850.17263.13;.
Cotter SE, Dunn GP, Collins KM, Sahni D, Zukotynski KA, Hansen JL, O'Farrell DA, Ng AK, Devlin PM, Wang LC. Abscopal effect in a patient with metastatic Merkel cell carcinoma following radiation therapy: potential role of induced antitumor immunity. Arch Dermatol. 2011 Jul; 147(7):870-2. PMID: 21768497; DOI: 10.1001/archdermatol.2011.176;.
Abbott RA, Sahni D, Robson A, Agar N, Whittaker S, Scarisbrick JJ. Poikilodermatous mycosis fungoides: a study of its clinicopathological, immunophenotypic, and prognostic features. J Am Acad Dermatol. 2011 Aug; 65(2):313-9. PMID: 21529998; DOI: 10.1016/j.jaad.2010.05.041;.
Cotter SE, Devlin PM, Sahni D, Hansen JL, O'Farrell DA, Ng AK, Wang LC. Treatment of cutaneous metastases of Merkel cell carcinoma with surface-mold computer-optimized high-dose-rate brachytherapy. J Clin Oncol. 2010 Sep 20; 28(27):e464-6. PMID: 20679604; DOI: 10.1200/JCO.2010.29.0635;.

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 22 publications over 8 distinct years, with a maximum of 7 publications in 2018